Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

被引:665
作者
De Hert, M. [1 ]
Dekker, J. M. [2 ,3 ]
Wood, D. [4 ]
Kahl, K. G. [5 ]
Holt, R. I. G. [6 ]
Moeller, H. -J. [7 ]
机构
[1] Ctr Catholic Univ, Univ Psychiat, Leuven Campus Kortenberg,Leuvensesteenweg 517, B-3070 Kortenberg, Belgium
[2] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, NL-1081 BT Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, EMGO, Inst Hlth & Care Res, NL-1081 BT Amsterdam, Netherlands
[4] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst Cardiovasc Sci, London W6 8RP, England
[5] Hannover Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, D-30625 Hannover, Germany
[6] Univ Southampton, Sch Med, Southampton SO16 6YD, Hants, England
[7] Univ Munich, Dept Psychiat, D-80336 Munich, Germany
关键词
Severe mental illness; Schizophrenia; Depression; Bipolar disorder; Physical health; Weight gain; INDUCED WEIGHT-GAIN; CATIE SCHIZOPHRENIA TRIAL; LIFE-STYLE INTERVENTION; ISCHEMIC-HEART-DISEASE; METABOLIC SYNDROME; ATYPICAL ANTIPSYCHOTICS; SCHIZOAFFECTIVE DISORDER; 2ND-GENERATION ANTIPSYCHOTICS; INSULIN SENSITIVITY; SEVERE DYSLIPIDEMIA;
D O I
10.1016/j.eurpsy.2009.01.005
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
People with severe mental illnesses, such as schizophrenia, depression or bipolar disorder, have worse physical health and reduced life expectancy compared to the general population. The excess cardiovascular mortality associated with schizophrenia and bipolar disorder is attributed in part to an increased risk of the modifiable coronary heart disease risk factors; obesity, smoking, diabetes, hypertension and dyslipidaemia. Antipsychotic medication and possibly other psychotropic medication like antidepressants can induce weight gain or worsen other metabolic cardiovascular risk factors. Patients may have limited access to general healthcare with less opportunity for cardiovascular risk screening and prevention than would be expected in a non-psychiatric population. The European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) published this statement with the aim of improving the care of patients suffering from severe mental illness. The intention is to initiate cooperation and shared care between the different healthcare professionals and to increase the awareness of psychiatrists and primary care physicians caring for patients with severe mental illness to screen and treat cardiovascular risk factors and diabetes. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:412 / 424
页数:13
相关论文
共 140 条
[11]   LITHIUM MAINTENANCE TREATMENT OF MANIC-MELANCHOLIC PATIENTS - ROLE IN DAILY ROUTINE [J].
BECH, P ;
VENDSBORG, PB ;
RAFAELSEN, OJ .
ACTA PSYCHIATRICA SCANDINAVICA, 1976, 53 (01) :70-81
[12]   WEIGHT-GAIN - A SIDE-EFFECT OF TRICYCLIC ANTIDEPRESSANTS [J].
BERKEN, GH ;
WEINSTEIN, DO ;
STERN, WC .
JOURNAL OF AFFECTIVE DISORDERS, 1984, 7 (02) :133-138
[13]  
Bjorntorp P, 1997, ACTA PHYSIOL SCAND, V161, P144
[14]   Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: Results of the CLAMORS Study [J].
Bobes, Julio ;
Arango, Celso ;
Aranda, Pedro ;
Carmena, Rafael ;
Garcia-Garcia, Margarida ;
Rejas, Javier .
SCHIZOPHRENIA RESEARCH, 2007, 90 (1-3) :162-173
[15]   Cardiovascular Abnormalities in Patients with Major Depressive Disorder Autonomic Mechanisms and Implications for Treatment [J].
Brown, Alex D. H. ;
Barton, David A. ;
Lambert, Gavin W. .
CNS DRUGS, 2009, 23 (07) :583-602
[16]   History of depression increases risk of type 2 diabetes in younger adults [J].
Brown, LC ;
Majumdar, SR ;
Newman, SC ;
Johnson, JA .
DIABETES CARE, 2005, 28 (05) :1063-1067
[17]   Causes of the excess mortality of schizophrenia [J].
Brown, S ;
Inskip, H ;
Barraclough, B .
BRITISH JOURNAL OF PSYCHIATRY, 2000, 177 :212-217
[18]   Excess mortality of schizophrenia - A meta-analysis [J].
Brown, S .
BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 :502-508
[19]  
BRUGGEMAN R, 2008, SCHIZOPHR RES, V102, P161, DOI DOI 10.1016/S0920-9964(08)70491-2
[20]   Clinicians' recognition of the metabolic adverse effects of antipsychotic medications [J].
Buckley, PF ;
Miller, DD ;
Singer, B ;
Arena, J ;
Stirewalt, EM .
SCHIZOPHRENIA RESEARCH, 2005, 79 (2-3) :281-288